Halda Therapeutics

The 2026 fiscal year was a record-breaking one for Connecticut Innovations, the state’s quasi-public venture capital arm.

Four years in, Yale's startup engine has spun out 51 companies and helped attract more than $600 million — and its managing director says the pipeline of ideas shows no signs of slowing.

A state fund that has backed more than 100 Connecticut bioscience startups since 2013 is running low on capital — and lawmakers are weighing whether to refill it.

Connecticut Innovations (CI), the state’s quasi-public venture capital arm, said Wednesday it generated about $41 million in returns during the second quarter of its fiscal year, which ended Dec. 31 — a sharp increase from $7 million in the first quarter.

Johnson & Johnson announced Monday morning it will acquire New Haven-based Halda Therapeutics for $3.05 billion in...